Find Clinical Trials
Servier Protocol Code:
CL2-18986-009
Sponsor:
Institut de Recherches Internationales Servier
Clinicaltrials.gov Identifier:
NCT00202540
EudraCT Number:
2004-004327-35
Find a recruiting site
How to participate in this study
If you think you are eligible for this study (see
below), you can identify the location closest to you and contact them directly. If you can’t find a location close to you, please contact Institut de Recherches Internationales Servier (I.R.I.S.)
eligibility criteria
Researchers look for people who fit a certain decription, called eligibility criteria. These include inclusion criteria and exclusion criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Name:
Institut de Recherches Internationales Servier, Département des études cliniques
Phone number:
+33 1 55 72 60 00
The study has 1 location
Study description
The purpose of this study is to demonstrate a long term efficacy of S18986 versus placebo on episodic memory performance in patients with MCI
Official title: Efficacy of 15 mg and 50 mg of S18986 on Cognitive Symptoms in Mild Cognitive Impairment Patients Treated Over a 12-month Oral Administration Period
Results
English (USA)Conditions
Mild Cognitive Impairment
Interventions / Treatments
The treatment(s) given to the participants in the study.
- S18986
Other study id numbers
Other identification numbers the study may be known by.
- CL2-18986-009
Eligibility Criteria
Researchers look for people who fit a certain decription, called eligibility criteria. These include inclusion criteria and exclusion criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligible age for the study
55 years and older
(Adult, Older Adult)
Sex
Male/FemaleAccepts Healthy Volunteers
No- * Memory complaint
- * Acetylcholinesterase inhibitors stopped at least 3 months before selection
- * Dementia
- * Parkinson's disease
- * Vascular disorder
- * Depression
- * Epilepsy
How is the study designed?
Allocation
How participants are assigned to different groups. Allocation can be random (randomized) or predetermined (non-randomized). Randomized means that participants are assigned at random to their participant group / arm.
Interventional study model
How treatments are given and tested in a study.
Parallel
A parallel study design compares two or more groups at the same time, with each group receiving a different treatment. Researchers then compare the results to determine which treatment is more effective.
Keywords
Additional Relevant MeSH Terms Glioma
Cognitive Dysfunction